Search Results - Kim Monkhorst
- Showing 1 - 14 results of 14
-
1
-
2
The probability to initiate X chromosome inactivation is determined by the X to autosomal ratio and X chromosome specific allelic properties. by Kim Monkhorst, Bas de Hoon, Iris Jonkers, Eskeatnaf Mulugeta Achame, Wouter Monkhorst, Jos Hoogerbrugge, Eveline Rentmeester, Hans V Westerhoff, Frank Grosveld, J Anton Grootegoed, Joost Gribnau
Published in PLoS ONE (2009-01-01)Get full text
Article -
3
Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer. by Karlijn Hummelink, Vincent van der Noort, Mirte Muller, Robert D Schouten, Michel M van den Heuvel, Daniela S Thommen, Egbert F Smit, Gerrit A Meijer, Kim Monkhorst
Published in PLoS ONE (2024-01-01)Get full text
Article -
4
Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC by Kim Monkhorst, Daniel Klass, Milou Schuurbiers, Zhongyun Huang, Senglor Saelee, Manana Javey, Leonie de Visser, Daan van den Broek, Michel van den Heuvel, Alexander F Lovejoy
Published in Journal for ImmunoTherapy of Cancer (2022-02-01)Get full text
Article -
5
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine by Krijn K. Dijkstra, Kim Monkhorst, Luuk J. Schipper, Koen J. Hartemink, Egbert F. Smit, Sovann Kaing, Rosa de Groot, Monika C. Wolkers, Hans Clevers, Edwin Cuppen, Emile E. Voest
Published in Cell Reports (2020-05-01)Get full text
Article -
6
External validation of a serum tumor marker algorithm for early prediction of no durable benefit to immunotherapy in metastastic non-small cell lung carcinoma by Milou M. F. Schuurbiers, Freek A. van Delft, Hendrik Koffijberg, Maarten J. IJzerman, Kim Monkhorst, Marjolijn J. L. Ligtenberg, Daan van den Broek, Huub H. van Rossum, Michel M. van den Heuvel
Published in Tumor Biology (2025-02-01)Get full text
Article -
7
Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer by Franziska Böttger, Teodora Radonic, Idris Bahce, Kim Monkhorst, Sander R. Piersma, Thang V. Pham, Anne‐Marie C. Dingemans, Lisa M. Hillen, Mariacarmela Santarpia, Elisa Giovannetti, Egbert F. Smit, Sjaak A. Burgers, Connie R. Jimenez
Published in Molecular Oncology (2024-06-01)Get full text
Article -
8
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production by Saskia D. van Asten, Rosa de Groot, Marleen M. van Loenen, Suzanne M. Castenmiller, Jeroen de Jong, Kim Monkhorst, John B.A.G. Haanen, Derk Amsen, Axel Bex, Robbert M. Spaapen, Monika C. Wolkers
Published in OncoImmunology (2021-01-01)Get full text
Article -
9
SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response by Sofía Ibáñez-Molero, Alex van Vliet, Joanna Pozniak, Karlijn Hummelink, Alexandra M. Terry, Kim Monkhorst, Joyce Sanders, Ingrid Hofland, Ewout Landeloos, Yannick Van Herck, Oliver Bechter, Thomas Kuilman, Weiwei Zhong, Jean-Christophe Marine, Lodewyk Wessels, Daniel S. Peeper
Published in OncoImmunology (2022-12-01)Get full text
Article -
10
Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products by Suzanne M. Castenmiller, Nandhini Kanagasabesan, Aurélie Guislain, Benoît P. Nicolet, Marleen M. van Loenen, Kim Monkhorst, Alexander A.F.A. Veenhof, Egbert F. Smit, Koen J. Hartemink, John B.A.G. Haanen, Rosa de Groot, Monika C. Wolkers
Published in OncoImmunology (2024-12-01)Get full text
Article -
11
Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study. by Milou M F Schuurbiers, Christopher G Smith, Koen J Hartemink, Robert C Rintoul, Davina Gale, Kim Monkhorst, Bas L R Mandos, Anna L Paterson, Daan van den Broek, Nitzan Rosenfeld, Michel M van den Heuvel, LEMA Study Group and the LUCID Study Group
Published in PLoS Medicine (2025-04-01)Get full text
Article -
12
Feasibility of Intracoronary GLP-1 Eluting CellBead Infusion in Acute Myocardial Infarction by Jaco H. Houtgraaf, Renate De Jong, Kim Monkhorst, Dennie Tempel, Esther Van De Kamp, Wijnand K. Den Dekker, Kushan Kazemi, Imo Hoefer, Gerard Pasterkamp, Andrew L. Lewis, Peter W. Stratford, Christine Wallrapp, Felix Zijlstra, Henricus J. Duckers M.D., Ph.D., FESC, FACC
Published in Cell Transplantation (2013-03-01)Get full text
Article -
13
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients by Ekaterina A. Semenova, Min-chul Kwon, Kim Monkhorst, Ji-Ying Song, Rajith Bhaskaran, Oscar Krijgsman, Thomas Kuilman, Dennis Peters, Wieneke A. Buikhuisen, Egbert F. Smit, Colin Pritchard, Miranda Cozijnsen, Jan van der Vliet, John Zevenhoven, Jan-Paul Lambooij, Natalie Proost, Erwin van Montfort, Arno Velds, Ivo J. Huijbers, Anton Berns
Published in Cell Reports (2016-07-01)Get full text
Article -
14
Longitudinal Circulating Tumor DNA–Guided Resistance Analysis During Second-Line Osimertinib Treatment by J.W. Tijmen van der Wel, MD, Merel Jebbink, MD, Vincent van der Noort, PhD, Ferry Lalezari, MD, PhD, Daan van den Broek, PhD, Gerrina Ruiter, MD, PhD, Jacobus A. Burgers, MD, PhD, Paul Baas, MD, PhD, Anne S.R. van Lindert, MD, Eva E. van der Wall, MD, Lisanne E.A. Kastelijn, MD, PhD, Marrit Vermeulen, BSc, Linda J.W. Bosch, PhD, Kim Monkhorst, MD, PhD, Mirjam C. Boelens, PhD, Egbert F. Smit, MD, PhD, Adrianus J. de Langen, MD, PhD
Published in JTO Clinical and Research Reports (2025-09-01)Get full text
Article